Motion-Secondary: PEREZ -V- LOMA LINDA UNIVERSITY, ET AL Print

• 
• 
• 
• 

						
                                
Preview
                                Gordon L. Dayton, Esq., (SBN: 208379)                                  ELECTRONICALLY FILED (Auto)
     LAW OFFICES OF GORDON L. DAYTON                                        SUPERIOR COURT OF CALIFORNIA
                                                                            COUNTY OF SAN BERNARDINO
     41856 Ivy Street, Suite 214
                                                                            1/4/2024 7:57 PM
     Murrieta, CA 92562
     Telephone (951) 296-5303 * Facsimile (951) 296-5319

     Attorney for Plaintiffs, ANTHONY L. PEREZ
             and SANDRA L. PEREZ




                     IN THE SUPERIOR COURT OF THE STATE OF CALIFORNIA

                                     COUNTY OF SAN BERNARDINO

     ANTHONY L. PEREZ, an individual, SANDRA L.            Case No. CIVDS1913814
10   PEREZ, an individual, ANTHONY L. PEREZ,
     Successor-in-Interest to the ESTATE OF JORDAN         DECLARATION OF JUDY L. SCHMIDT, MD,
1]   LEE PEREZ, and SANDRA L. PEREZ, Successor-            FACP IN SUPPORT OF PLAINTIFFS’ OPPO-
     in-Interest to the ESTATE OF JORDAN LEE               SITION TO DEFENDANTS’ LOMA LINDA
12   PEREZ                                                 UNIVERSITY HEALTH, CHELSEA L.
                                                           COLLINS M.D., ALBERT KHERADPOUR
13                                     Plaintiffs,         M.D., CHENUE ABONGWA M.D., AND
                                                           BATUL SUTERWALA M.D.’S MOTION FOR
14                                                         SUMMARY JUDGMENT OR SUMMARY AD-
                          VS.                              JUDICATION OR BOTH
15
                                                           ACTION FILED: May 6, 2019
16   LOMA LINDA UNIVERSITY HEALTH, a non-                  FAC FILED: July 31, 2019
     profit corporation; LOMA LINDA UNIVERSITY             SAC FILED: January 8, 2020
17   MEDICAL CENTER, a nonprofit corporation;              TAC: June 2, 2020
     LOMA LINDA UNIVERSITY CHILDREN'S                      FRAC FILED: November    19, 2020
18   HOSPITAL a nonprofit corporation; ALBERT              TRIAL DATE: None Set
     KHERADPOUR M._D., an individual; CHENUE
19   ABONGWA M..D., an individual; CHELSEA L.
     COLLINS M.D., an individual; BATUL SUTER-
20   WALA M.D., an individual; VENKATRAMAN
     SADANAND M.D., an individual; ALEXANDER
21   ZOUROS M.D, an individual; YUTHANA KONG,
     P.A., an individual; PILAR D. PICHON M.D., an
22   individual; GAMIL FTEEH M.D., an individual;
     THOMAS P. BRAVO M.D., an individual; MAR-
23   QUELLE J. KLOOSTER M.D., an individual;
     KHYATI P. MEHTA M.D., an individual; KIM-
24   BERLY R. ZIMMERMAN M.D., an individual;

                DECLARATION OF JUDY L. SCHMIDT, MD, FACP IN SUPPORT OF OPPOSITION TO
                           DEFENDANTS’ MOTION FOR SUMMARY JUDGEMENT
     SARAH C. PETERSON M.D., an individual;
     BESH R. BARCEGA M.D., an individual;
     NATASHA    Y. LI M.D., an individual; LANCE A.
     BROWN M.D., an individual; TOMMY Y. KIM
     M.D., an individual; ANDREA W. THORP M.D, an
     individual; DAVID RICHTER M_D., an individual,
     and DOES 2-200, inclusive,

                                          Defendants.




             I, Judy L. Schmidt, MD, FACP, declare and state, that if called upon to testify and sworn, I

     could and would testify to the following facts of my own personal knowledge.

     Qualifications and Credentials

10       1. 1 am atriple board certified Internist, Hematologist and Medical Oncologist. My three year

1]   subspecialty fellowship training in Hematology and Medical Oncology was completed at the Mayo

12   Clinic in Rochester, Minnesota in 1988. Patients traveled from all over the world to obtain second

13   opinions and medical care from the Mayo Clinic. As a Fellow in Hematology and Medical Oncol-

14   ogy, I was exposed to a plethora of patients with thrombophilia and many patients with myeloprolif-

15   erative neoplasms. I worked along side world experts in myeloproliferative neoplasms and throm-

16   bophilia.

17       2. In 1988, I moved to Missoula, Montana and practiced community-based private practice

18   Hematology and Medical Oncology for 22 years. Eighty percent of Hematology/Oncology is prac-

19   ticed by community-based physicians. I was a clinical instructor for the University of Washington

20   WAMI (Washington/Alaska/Montana/Idaho) program for several years teaching the University Med-

21   ical Students Hematology and Oncology. In my solo Montana practice, I was responsible for the in-

22   ternal medicine care of over 95% of the patients I cared for. I was involved in the diagnosis and

23   treatment of hundreds and hundreds of thrombophilia patients; including patients with myeloprolif-

24   erative neoplasms.
                                                         2
                 DECLARATION OF JUDY L. SCHMIDT, MD, FACP IN SUPPORT OF OPPOSITION TO
                            DEFENDANTS’ MOTION FOR SUMMARY JUDGEMENT